Introduction
Cytochrome P450 (CYP) enzymes belong to a superfamily of hemoproteins that play central roles in the oxidative metabolism of numerous endogenous substrates such as [Human Cytochrome P450 (CYP) Allele Nomenclature Committee, http://www.imm.ki.se/CYPalleles/]. CYP3A4 is most abundant in adult liver (Wrighton and Stevens. 1992) ; this enzyme metabolizes approximately 50% of the drugs in current use as well as a number of steroids, environmental chemicals, and carcinogens (Thummel and Wilkinson 1998; Guengerich 1999) . Nonsynonymous SNPs in CYP3A4 have been identified in various ethnic populations (Sata et al. 2000; Dai et al. 2001; Eiselt et al. 2001; Hsieh et al. 2001; Lamba et al. 2002) , and Rebbeck et al. (1998) have reported association between an SNP in the 5Ј flanking region of the CYP3A4 gene and advanced prostate cancer. Expression levels of CYP3A4, CYP3A5, and CYP3A7 vary widely among individuals; measurements of CYP3A4 activities in adults reveal 10-to 40-fold differences (de Wildt et al. 1999) . CYP3A5 also shows heterogeneity of expression in liver (Lown et al. 1994) , and SNPs resulting in alternative splicing and an absence of CYP3A5 protein have been found in some individuals (Kuehl et al. 2001) . CYP3A7, on the other hand, is expressed mainly in fetal liver; this enzyme seems to disappear shortly after birth, although some people continue to express CYP3A7 mRNA even in adulthood (Schuetz et al. 1994) .
Animal experiments have revealed an important role of CYP4B1 in mutagenic activation of procarcinogens in the urinary bladder (Imaoka et al. 1997) . Bladder-tumor patients, indeed, show significantly higher expression of CYP4B1 than do patients with other types of cancer (Imaoka et al. 2000) .
CYP4F2, CYP4F3, and CYP4F8 were originally cloned from human neutrophils, liver, and seminal vesicle, respectively (Kikuta et al. 1993 (Kikuta et al. , 1994 Bylund et al. 1999 ). CYP4F2 and CYP4F3 are also called leukotriene B4 (LTB4) omegahydroxylases because they possess efficient catalytic activity toward LTB4, an important chemotactic and chemokinetic participant in the inflammatory response.
CYP27A1 (sterol 27-hydroxylase) catalyzes the first step in oxidation of the side chains of sterol intermediates during synthesis of bile acids . Mutations in the CYP27A1 gene cause cerebrotendinous xanthomatosis, a rare autosomal recessive defect of lipid storage . CYP27B1, also known as 25-hydroxyvitamin D 3 1alpha-hydroxylase (1alpha-hydroxylase), catalyzes the conversion of 25-hydroxyvitamin D 3 to 1alpha, 25-dihydroxyvitamin D 3 . This enzyme plays an important role in calcium homeostasis (Takeyama et al. 1997) . Mutations in the CYP27B1 gene cause pseudovitamin D-deficiency rickets (Fu et al. 1997; Kitanaka et al. 1998; Wang et al. 1998) .
The aldehyde dehydrogenase (ALDH; EC 1.2.1.3) superfamily involves a group of NAD (P) ϩ -dependent enzymes that catalyze the oxidation of a wide spectrum of endogenous and exogenous aldehydes (Lindahl 1992) . Thus far, 17 functional ALDH genes and three pseudogenes have been identified in the human genome and some polymorphisms have been reported already (Yoshida et al. 1998; Vasiliou and Pappa 2000; Sophos et al. 2001 ; Aldehyde Dehydrogenase Gene Superfamily Database, http://www.uchsc.edu/sp/sp/alcdbase/aldhcov.html).
The ALDH1 subfamily consists of five genes, ALDH1A1, ALDH1A2, ALDH1A3, ALDH1B1, and ALDH1L1. ALDH1A1 is a cytosolic enzyme ubiquitously distributed in human tissues, including brain and red blood cells (Yoshida 1992) . Several ALDH1A1 variants have been associated with various degrees of enzyme deficiency in the liver and red blood cells (Yoshida et al. 1989; Yoshida 1992) . Mitochondrial ALDH1B1 is expressed in liver, kidney, muscle, heart, and placenta ; this enzyme may play a role in ethanol detoxification (Stewart et al. 1995) . Although three polymorphisms have been reported in its coding regions, no significant difference has been found in the allelic frequencies of those polymorphisms between alcoholic versus nonalcoholic Caucasians (Sherman et al. 1993) . ALDH1A2 is involved in retinal metabolism (Wang et al. 1996) . ALDH1A3 is expressed in salivary gland, stomach, and kidney (Hsu et al. 1994) . The ALDH1L1 gene encodes a 10-formyltetrahydrofolate dehydrogenase (Champion et al. 1994) .
ALDH2, a mitochondrial enzyme, is highly expressed in various tissues but predominantly in the liver . ALDH2 exhibits strong oxidative activity toward acetaldehyde, and plays a major role in its detoxification (Lindahl 1992) . In oriental populations, alcohol sensitivity is associated with a genetic deficiency of ALDH2 caused by a G-to-A mutation in exon 12 (Yoshida et al. 1985) . A polymorphism in the human ALDH2 promoter was recently described (Chou et al. 1999; Harada et al. 1999 ), but it is not clear whether this polymorphism affects alcohol metabolism.
The ALDH3 subfamily consists of four genes, ALDH3A1, ALDH3A2, ALDH3B1, and ALDH3B2. ALDH3A1 is a cytosolic enzyme highly expressed in stomach and lung, and at low (or undetectable) levels in normal liver (Lindahl 1992) . Although a C-to-G polymorphism (Pro329Ala) has been reported in Caucasian and Asian populations (Tsukamoto et al. 1997) , its biological effects are currently unknown. ALDH3A2, a microsomal enzyme constitutively expressed in several tissues, catalyzes oxidation of fatty aldehydes (Rizzo and Craft 1991; Chang and Yoshida 1997) . Mutations in ALDH3A2 that cause loss of enzymatic activity are responsible for Sjögren-Larsson syndrome (De Laurenzi et al. 1996) . Hsu et al. (1997) determined the structures of the ALDH3B1 and ALDH3B2 genes, but the function of neither enzyme is known at present.
ALDH5A1 is highly expressed in brain as well as in liver, pituitary, heart, and ovary (Chambliss et al. 1995) . Mutations in the ALDH5A1 gene cause succinic semialdehyde dehydrogenase deficiency, a rare inborn error of the neurotransmitter 4-aminobutyric acid (Chambliss et al. 1998) . ALDH6A1 is the only CoA-dependent dehydrogenase in the ALDH family (Goodwin et al. 1989 ). Lin and Napoli (2000) isolated a cDNA encoding ALDH8A1. Allelic variants of the ALDH9A1 gene, which encodes an enzyme that catalyzes dehydrogenation of gammaaminobutyraldehyde to gamma-aminobutyric acid (Kurys et al. 1989) , have been reported but not yet characterized (Lin et al. 1996) .
To investigate in more detail the nature of apparent genotype/phenotype correlations for some CYP or ALDH enzymes, we began by searching for additional SNPs in the 13 CYP genes and 14 ALDH genes described earlier, including their promoter regions and introns, except for repetitive elements, and report here a total of 906 genetic variations, of which 627 had not been reported before.
Subjects and methods
Total genomic DNAs were isolated from peripheral leukocytes of 48 unrelated Japanese individuals by the standard phenol/chloroform extraction method. Informed consent was obtained from each participant. On the basis of sequence information in GenBank, we designed polymerase chain reaction (PCR) primers to amplify DNA from all 27 genes in their entirety, except that repetitive elements were excluded by invoking the REPEAT MASKER computer program (http://ftp.genome.washington.edu/ cgi-bin/RepeatMasker). PCR experiments and DNA sequencing were performed according to methods described previously Saito et al. 2001; Sekine et al. 2001) . All SNPs detected by the PolyPhred Computer Program (Nickerson et al. 1997) were confirmed by sequencing both strands of each PCR product.
Results
Exon-intron boundaries within each of the 27 genes were defined by comparison of genomic sequences with cDNA sequences. Accession numbers of the genomic sequences and the cDNA sequences used for this study are listed in Table 1 . We screened 96 Japanese chromosomes for SNPs in 13 CYP genes and 14 ALDH genes by direct DNA sequencing. Re-sequencing a total of about 430 kb of genomic DNA (148.5 kb for the CYP genes, 281.6 kb for ALDHs) identified 810 SNPs (229 in CYPs and 581 in ALDHs) and 96 insertion/deletion polymorphisms (31 in CYPs and 65 in ALDHs) (Tables 2 and 3 , respectively). Among the 906 genetic variations identified in our screening, including insertion/deletion polymorphisms, 627 (69%; 157 in CYPs and 470 in ALDHs) had not been reported previously.
CYP genes
Figure 1 (a-m) illustrates the location of each variation in the CYP genes; detailed information about nucleotide positions and substitutions is summarized in ALDH genes
Figure 2 (a-n) illustrates the location of each variation found in ALDH genes; detailed information regarding nucleotide positions and substitutions is summarized in Table 7 (a-n). Numbers of SNPs are summarized in Table 8 . Among the 581 ALDH SNPs detected in our Japanese sample population, 29 were located in 5Ј flanking regions, 460 in introns, 51 in exons, and 41 in 3Ј flanking regions. Of the 51 SNPs detected in exons, 3 were located in 5Ј UTRs, 29 in coding regions, and 19 in 3Ј UTRs. Among the 29 SNPs detected in coding regions, 19 would cause substitution of an amino acid and 10 of those were novel. Among the ten synonymous SNPs, three were novel (Table  9) . 
Intron 1 1357
Exon 7 UTR, untranslated region; del, deletion; ins, insertion a For SNPs in the 5Ј flanking region, intron, or 3Ј flanking region, nucleotide positions are counted from the first intronic nucleotide at the exon/intron junction (for SNPs in the exon, nucleotide positions are counted from the first exonic nucleotide at the exon/intron junction) b SNP previously reported by Hayashi et al. (1991) c SNP previously reported by Spurr et al. (1987) Exon 7 295 C/T(Asn516Asn) rs2470890 CYP1A2, Cytochrome P450, subfamily I (aromatic compoundinducible), polypeptide 2 b SNPs previously reported by Chida et al. (1999) c SNP previously reported by Sachse et al. (1999) untranslated region (UTR), 26 were in coding regions, and 13 were in 3Ј UTRs. Among the 26 SNPs detected in coding regions, 15 would cause substitution of an amino acid and 5 of those were novel. Among the 11 SNPs that were synonymous, 4 were novel (Table 6 ). Aldehyde dehydrogenase 1 family, member A1 (ALDH1A1) 
Fig. 2a-n. Locations of SNPs in the ALDH1A1
(a), ALDH1A2 (b), ALDH1A3 (c), ALDH1B1 (d), ALDH1L1 (e), ALDH2 (f), ALDH3A1 (g), ALDH3A2 (h), ALDH3B1 (i), ALDH3B2 (j), ALDH5A1 (k), ALDH6A1 (l), ALDH8A1(
Discussion
We identified a total of 906 genetic variations (810 SNPs and 96 insertion/deletion polymorphisms) by screening DNA from 48 unrelated Japanese individuals in the entire genomic regions, except for repetitive sequences, encoding 13 CYP and 14 ALDH genes. All data on these SNPs are available on our website (http://snp.ims.u-tokyo.ac.jp/). Cytochrome P450 (CYP) enzymes play central roles in the oxidative metabolism of numerous endogenous substrates such as steroid hormones and of xenobiotics, including various carcinogens and toxins (Denison and Whitlock 1995; Nelson et al. 1996) . Others had detected 30 polymorphisms that would affect amino acid sequences (3 in CYP1A1, 5 in CYP1A2, 18 in CYP3A4, and 4 in CYP3A5) (Cascorbi et al. 1996; Jounaidi et al. 1996; Huang et al. 1999; Sata et al. 2000; Chevalier et al. 2001a,b; Chou et al. 2001; Dai et al. 2001; Eiselt et al. 2001; Hsieh et al. 2001; Hustert et al. 2001; Lamba et al. 2002) . However, among the 30 polymorphisms reported previously, we could find in our Japanese subjects only one, an ins/del polymorphism in CYP3A4, that causes a frameshift and results in early termination of translation at exon 9. This polymorphism was also reported in the Chinese population (Hsieh et al. 2001 ). On the other hand, we were able to find two novel nonsynonymous substitutions (Gly45Asp in CYP1A1 and Gln478His in CYP1A2). These results indicated that archived polymorphisms may be very rare substitutions or limited to specific ethnic groups.
In the 5Ј flanking region of the CYP1A1 gene, we identified putative xenobiotic response elements, which control expression of this enzyme (Corchero et al. 2001) . A 3-kb 5Ј flanking portion of the human CYP1B1 gene also Sherman et al. (1993) Nuclear receptor steroid and xenobiotic receptor/pregnenolone X receptor (SXR/PXR) binds to a PXR response element present in CYP3A promoters and activates CYP3A genes (Goodwin et al. 1999; Xie et al. 2000) . Because expression levels of CYP3A differ widely among individuals and the promoters contain multiple putative transcriptionfactor-binding sites, polymorphisms in the 5Ј flanking regions have been investigated intensively (Paulussen et al. 2000; Hustert et al. 2001; Kuehl et al. 2001 ). However, we found only two SNPs in the CYP3A7 promoter region in the Japanese population by screening a 2-kb segment of 5Ј flanking DNA.
ALDH genes are considered general detoxifying enzymes that eliminate biogenic and xenobiotic aldehydes (Lindahl 1992) . Although 17 functional ALDH genes and three pseudogenes have been identified already in the human genome, biological functions of some ALDHs remain unclear (Yoshida et al. 1998; Sophos et al. 2001; Vasiliou and Pappa 2000) . Polymorphisms in ALDH genes are ethnically diverse; previously reported polymorphisms (Glu479Lys in ALDH2, Gly214Tyr in ALDH3A2, Cys115Ser in ALDH9A1) (Novoradovsky et al. 1995 ; De contains multiple core recognition motifs for binding to dioxin-responsive enhancer and Sp1 elements (Tang et al. 1996) . We found four SNPs (-1061, -1035, -1020, and -947) in this region of CYP1A1, and three (-1222, -376, and -265) in CYP1B1 that might influence transcriptional efficiencies. Chou et al. (1999) c SNP previously reported by Harada et al. (1999) d SNP previously reported by Yoshida et al. (1985) Laurenzi et al. 1996; Lin et al. 1996) were not found in our examination of a Japanese test population. However, we did identify ten novel nonsynonymous polymorphisms in other ALDH genes. The polymorphisms published here should be useful for investigating relationships between individual genotypes and susceptibility to certain diseases and/or the potential efficacy or adverse effects of certain drugs.
